Compare Davita Inc (DVA) vs Microsoft (MSFT) Price & Performance

Davita IncTrade

MicrosoftTrade

Price performance (Past 24H)

Key statistics

Davita Inc vs Microsoft — how do they compare? Davita Inc trades at $232 (market cap $15.12B), while Microsoft trades at $386.66 (market cap $2.90T). The key difference: Microsoft is far larger — about 191.8× Davita Inc's market cap, and Microsoft pays a 0.93% dividend while Davita Inc pays none. Which is the better fit depends on your goals.

	DVA	MSFT
Market Cap	$15.12B	$2.90T
Sector	Health	Technology
52-Week High	$235.71	$542.07
52-Week Low	$103.87	$352.83
Enterprise Value	$27.67B	$2.88T
Volume	—	36,654,621
Dividend Yield	—	0.93%

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Davita Inc

No Aura AI signal available yet.

Microsoft

Microsoft (MSFT) trades at $390.99, up 1.53% today, with a neutral technical signal and strong fundamental performance. The company reported consistent earnings beats in recent quarters, with Q1 2026 EPS of $4.27 exceeding the $4.06 estimate. Revenue growth remains robust at $281.72B for 2025, supported by 68.31% gross margins and $136.16B in operating cash flow. Analyst consensus is overwhelmingly bullish with 80.49% buy ratings and a $552.81 price target, representing 41% upside potential from current levels.

Microsoft's AI leadership and cloud momentum position it for continued growth, though elevated capital expenditures and competitive pressures present near-term headwinds. The stock's current valuation at 23.29 P/E appears reasonable given the company's strong profitability and growth trajectory. Institutional ownership remains substantial, with recent news highlighting Azure's strength and Copilot adoption as key catalysts.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

DVA

View details →

MSFT

Microsoft remains a Strong Buy despite stock dips and high CapEx concerns, with solid long-term growth potential.Seeking Alpha · 14 hours agoBullish IBM warns of slowing growth as AI shifts corporate spending to infrastructure, shares plunge 25%.New York Post · 21 hours agoBearish Tech dividend fund STK hits decade-low price with 3.7% yield, offering a strong buy opportunity amid market pause.Forbes · 22 hours agoBullish View details →

About Davita Inc

DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,100 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives approximately 69% of U.S. sales at government (primarily Medicare) reimbursement rates, with the remaining 31% coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.

About Microsoft

Microsoft Corporation develops, manufactures, licenses, sells, and supports software products. The Company offers operating system software, server application software, business and consumer applications software, software development tools, and Internet and intranet software. Microsoft also develops video game consoles and digital music entertainment devices.